Literature DB >> 8432485

Results of extracorporeal shock wave lithotripsy of gall bladder stones in 693 patients: a plea for restriction to solitary radiolucent stones.

A Elewaut1, A Crape, M Afschrift, W Pauwels, M De Vos, F Barbier.   

Abstract

During a period of 24 months 693 consecutive patients with symptomatic gall bladder stones (526 males, 167 females; mean age 51 years, range 18-89) were treated by extracorporeal shock wave lithotripsy with a Piezolith 2300. The procedure was carried out on an out-patient basis without analgesics or sedatives. Concomitant chemolitholytic treatment (ursodeoxycholic and chenodeoxycholic acid 7.5 mg/kg/day each) was administered until three months after total fragment clearance for a maximum therapy period of 1.5 years. In 601 patients with radiolucent stones complete clearance of all fragments was obtained after three, six, 12, and 18 months in respectively 20, 41, 64, and 78%. Actuarial analysis of the subgroups according to the stone mass (size and number) selected an ideal patient population with solitary stones less than 20 mm diameter (84% stone free after one year). The results are significantly less good when the greater the number of stones or their maximal diameter increases. Treatment was interrupted in 3.6% of the patients. In 90 sludge or fragments remain present. Twenty five patients were lost to follow up for non-biliary reasons. Stone recurrence was 5.7% at one year and was observed both in patients with solitary and multiple stones. A cost effectiveness analysis suggests that laparoscopic cholecystectomy is the most effective and economic solution, although extracorporeal shock wave lithotripsy for solitary radiolucent stones less than 2 cm is cheaper than conventional cholecystectomy. Extracorporeal shock wave lithotripsy for multiple stones is the most expensive and least effective option.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432485      PMCID: PMC1373984          DOI: 10.1136/gut.34.2.274

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  Fragmentation of biliary calculi by means of extracorporeally generated piezoelectric shock waves.

Authors:  C Ell; W Kerzel; H Langer; N Heyder; E Foerster; W Domschke
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

2.  Piezoelectric lithotripsy of gallstones.

Authors:  C Ell; W Kerzel; N Heyder; V Becker; P Hermanek; W Domschke
Journal:  Lancet       Date:  1987-11-14       Impact factor: 79.321

3.  Shock-wave lithotripsy of gallbladder stones. The first 175 patients.

Authors:  M Sackmann; M Delius; T Sauerbruch; J Holl; W Weber; E Ippisch; U Hagelauer; O Wess; W Hepp; W Brendel
Journal:  N Engl J Med       Date:  1988-02-18       Impact factor: 91.245

4.  [Piezoelectric lithotripsy of gallstones. Initial clinical experiences].

Authors:  C Ell; W Kerzel; N Heyder; E Günter; W Rödl; H Flügel; W Domschke
Journal:  Dtsch Med Wochenschr       Date:  1988-09-30       Impact factor: 0.628

5.  Use of external shock-wave lithotripsy and adjuvant ursodiol for treatment of radiolucent gallstones. A national multicenter study.

Authors:  D Burnett; A Ertan; R Jones; J P O'Leary; R Mackie; J E Robinson; G Salen; L Stahlgren; D H Van Thiel; L Vassy
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

6.  Gallstone recurrence after medical dissolution. An overestimated threat?

Authors:  A Lanzini; R P Jazrawi; R M Kupfer; D P Maudgal; A E Joseph; T C Northfield
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

7.  Piezoelectric lithotripsy in the treatment of symptomatic gallstone patients. A 12-month follow-up.

Authors:  J F Riemann; H E Adamek; J Weber
Journal:  J Clin Gastroenterol       Date:  1991-08       Impact factor: 3.062

8.  Gallstone disappearance after extracorporeal lithotripsy and oral bile acid dissolution.

Authors:  T Ponchon; A N Barkun; B Pujol; J L Mestas; R Lambert
Journal:  Gastroenterology       Date:  1989-08       Impact factor: 22.682

9.  A survey of the acoustic output of commercial extracorporeal shock wave lithotripters.

Authors:  A J Coleman; J E Saunders
Journal:  Ultrasound Med Biol       Date:  1989       Impact factor: 2.998

10.  Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.

Authors:  M Podda; M Zuin; P M Battezzati; C Ghezzi; C de Fazio; M L Dioguardi
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

View more
  6 in total

1.  Extracorporeal shock wave lithotripsy and gall bladder stones.

Authors:  A G Johnson; B Ross
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

Review 2.  Gastroenterology--II: Small and large bowel, pancreas and biliary system.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  1994-09       Impact factor: 2.401

3.  Gallstone dissolution with oral bile acid therapy. Importance of pretreatment CT scanning and reasons for nonresponse.

Authors:  S P Pereira; M J Veysey; C Kennedy; S H Hussaini; G M Murphy; R H Dowling
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

Review 4.  Evidence-based clinical practice guidelines for cholelithiasis 2016.

Authors:  Susumu Tazuma; Michiaki Unno; Yoshinori Igarashi; Kazuo Inui; Kazuhisa Uchiyama; Masahiro Kai; Toshio Tsuyuguchi; Hiroyuki Maguchi; Toshiyuki Mori; Koji Yamaguchi; Shomei Ryozawa; Yuji Nimura; Naotaka Fujita; Keiichi Kubota; Junichi Shoda; Masami Tabata; Tetsuya Mine; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-12-10       Impact factor: 7.527

5.  Role of extracorporeal shock wave lithotripsy in hepato-biliary-pancreatic surgery.

Authors:  R L van der Hul; P W Plaisier; O T Terpstra; H A Bruining
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

6.  Gallbladder stone recurrence after medical treatment. Do gallstones recur true to type?

Authors:  S P Pereira; S H Hussaini; C Kennedy; R H Dowling
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.